DEF 14A: Femasys Inc. Announces Details for 2024 Annual Stockholders Meeting

Femasys Inc. will hold its 2024 Annual Meeting of Stockholders on July 12, 2024, to elect a director and ratify the appointment of its independent accounting firm.

Summary

• Femasys Inc. has announced its 2024 Annual Meeting of Stockholders, scheduled for July 12, 2024, at 9:00 a.m. Eastern Daylight Time, at the company's offices in Suwanee, Georgia.
• Stockholders of record as of June 7, 2024, are eligible to vote on the proposals outlined in the proxy statement.
• The meeting will address the election of one Class III director to serve a three-year term expiring at the 2027 annual meeting and the ratification of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
• The board of directors recommends voting FOR the election of Kathy Lee-Sepsick as director and FOR the ratification of KPMG LLP.
• Stockholders can vote by internet, telephone, or mail, as instructed in the proxy materials.
• The company's board of directors is composed of five directors divided into three classes with staggered three-year terms.
• The proxy statement also details information on board committees, director compensation, executive compensation, security ownership, and related party transactions.

Sentiment

Score: 7

Explanation: The document is primarily informational and procedural, with a neutral to slightly positive tone due to the invitation to participate and the emphasis on good corporate governance.

Positives

• The company has a strong commitment to good corporate governance practices.
• The board of directors is composed of a majority of independent directors.
• The company has adopted a clawback policy for executive compensation.
• The company encourages board members to attend the annual stockholder meetings.

Negatives

• One late filing of a Form 4 for Ms. Thomas on November 1, 2023, reporting a transaction that occurred on October 10, 2023.

Risks

• The proxy statement mentions risks related to credit, liquidity, and operations, which are overseen by the board.
• Cybersecurity risks are also mentioned as part of the audit committee's oversight.
• The company's success depends on key personnel, including Kathy Lee-Sepsick.

Future Outlook

The board of directors does not presently intend to bring any other business before the Annual Meeting except as specified in the proxy materials.

Management Comments

• Kathy Lee-Sepsick, Founder, President and Chief Executive Officer, cordially invites stockholders to attend the 2024 Annual Meeting.
• The board of directors believes that separation of the positions of chairman and Chief Executive Officer reinforces the independence of the Board from management.

Industry Context

Femasys operates in the medical technologies industry, specifically focusing on women's health.

Comparison to Industry Standards

• The document does not provide specific comparisons to industry standards.
• However, it mentions that director compensation and executive compensation are designed to be competitive within the industry.
• The company's corporate governance practices are aligned with Nasdaq rules and SEC regulations.

Management Changes

Corporate Governance

Related Party Transactions

• The company employs the daughter of Ms. Lee-Sepsick, with total compensation and benefits less than $150,000, consistent with other employees with equivalent qualifications.
• In November 2023, the Company issued unsecured convertible notes and accompanying Series A and Series B Warrants in an aggregate principal amount of $6,850,000, including issuance of a $5 million convertible note and Series A and Series B Warrants to PharmaCyte Biotech, Inc.

Stakeholder Impact

• Shareholders are encouraged to participate in the Annual Meeting and vote on the proposals.
• Employees are eligible to participate in the company's 401(k) plan and health and welfare plans.
• The company's performance and governance practices impact investor confidence.

Next Steps

• Stockholders are encouraged to vote on the proposals before the Annual Meeting.
• The company will announce preliminary voting results at the Annual Meeting and disclose voting results on a Form 8-K.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Board of Directors, Stockholders, Director Election, KPMG LLP, Executive Compensation, Corporate Governance, Femasys